as per attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxfab Enterprises has allotted 2,04,04,371 fully convertible warrants at Rs. 21.02 per warrant to 50 investors on a preferential basis, each convertible into one equity share within 18 months. Separately, 21,27,689 equity shares were allotted at Rs. 21.02 each (aggregating Rs. 4.47 crore) to 41 warrant holders upon conversion of previously issued warrants, with the balance Rs. 15.765 per share paid at the time of conversion. After these allotments, the company's paid-up equity share capital has risen to Rs. 10.52 crore, comprising 1,05,27,689 equity shares of Rs. 10 face value. The allotments were done on a preferential basis at a price significantly above face value.
Shareholders face meaningful dilution with over 2.25 crore shares (warrants plus conversions) being added to the capital base. The fresh capital infusion may support business growth, but near-term stock sentiment could be pressured by the dilution overhang from the large outstanding warrants.